596 related articles for article (PubMed ID: 28522212)
1. Bioengineering bacterial outer membrane vesicles as vaccine platform.
Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
[TBL] [Abstract][Full Text] [Related]
2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
[TBL] [Abstract][Full Text] [Related]
3. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
Yi J; Liu Q; Kong Q
Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
[TBL] [Abstract][Full Text] [Related]
4. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
[TBL] [Abstract][Full Text] [Related]
6. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
7. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
8. Gram-negative outer membrane vesicles in vaccine development.
Collins BS
Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
[TBL] [Abstract][Full Text] [Related]
9. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
[TBL] [Abstract][Full Text] [Related]
10. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
11. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
12. OMV Vaccines and the Role of TLR Agonists in Immune Response.
Mancini F; Rossi O; Necchi F; Micoli F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
[TBL] [Abstract][Full Text] [Related]
13. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
Persson G; Pors SE; Thøfner ICN; Bojesen AM
Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
[TBL] [Abstract][Full Text] [Related]
15. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as platform vaccine technology.
van der Pol L; Stork M; van der Ley P
Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
Lee J; Kim OY; Gho YS
Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
[TBL] [Abstract][Full Text] [Related]
18. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The
König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G
Front Immunol; 2021; 12():752168. PubMed ID: 34819933
[TBL] [Abstract][Full Text] [Related]
19. Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract.
Carvalho AL; Fonseca S; Miquel-Clopés A; Cross K; Kok KS; Wegmann U; Gil-Cordoso K; Bentley EG; Al Katy SHM; Coombes JL; Kipar A; Stentz R; Stewart JP; Carding SR
J Extracell Vesicles; 2019; 8(1):1632100. PubMed ID: 31275534
[TBL] [Abstract][Full Text] [Related]
20. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
